| Juvenile Rheumatoid Arthritis (JRA) |
1 |
1 |
| Child |
0 |
0.95 |
| Remission |
0 |
0.99 |
| Arthritis |
0 |
0.41 |
| Psoriatic Arthritis |
0 |
0.4 |
| HIV Infection |
0 |
0.28 |
| Patient Safety |
0 |
0.75 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.16 |
| Hospital |
0 |
0.16 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.09 |
| Adverse Effects |
0 |
0.08 |
| Disease Recurrence |
0 |
0.08 |
| Glucocorticoid |
0 |
0.08 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.08 |
| Pandemic |
0 |
0.08 |
| Rheumatic Disease |
0 |
0.08 |
| Tumor |
0 |
0.08 |